Aerovate Therapeutics, Inc. (AVTE): Price and Financial Metrics
AVTE Price/Volume Stats
| Current price | $93.80 | 52-week high | $96.95 |
| Prev. close | $2.68 | 52-week low | $1.25 |
| Day low | $92.04 | Volume | 29,368 |
| Day high | $96.95 | Avg. volume | 269,597 |
| 50-day MA | $2.53 | Dividend yield | N/A |
| 200-day MA | $2.32 | Market Cap | 2.72B |
AVTE Stock Price Chart Interactive Chart >
Aerovate Therapeutics, Inc. (AVTE) Company Bio
Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
AVTE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AVTE Price Returns
| 1-mo | N/A |
| 3-mo | 5.93% |
| 6-mo | -0.37% |
| 1-year | -87.08% |
| 3-year | -78.54% |
| 5-year | N/A |
| YTD | 1.13% |
| 2024 | -88.29% |
| 2023 | -22.76% |
| 2022 | 148.52% |
| 2021 | N/A |
| 2020 | N/A |